SCHEMBL30008705

SCHEMBL30008705

COc1cc(Cl)c2[nH]c(C(N)=O)cc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 7/20 0.42
PDGFRB P09619 3/20 0.41
PDGFRA P16234 2/20 0.41
HRH4 Q9H3N8 2/20 0.40
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
HPGD P15428 2/20 0.39
MAPT P10636 1/20 0.39
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
NPC1 O15118 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29062726 1.00 FLT3 (0.42) FLT3PDGFRBPDGFRAHRH4KDM4E
SCHEMBL30310393 0.86 KDM4E (0.54) FLT3PDGFRBPDGFRAHRH4KDM4E
SCHEMBL24020626 0.86 KDM4E (0.54) FLT3PDGFRBPDGFRAHRH4KDM4E
SCHEMBL24019691 0.80 ALOX15 (0.51) FLT3PDGFRBPDGFRAHRH4KDM4E
SCHEMBL4386339 0.80 HPGD (0.60) KDM4EALDH1A1LMNAHPGDMAPT
SCHEMBL24740405 0.79 ALOX15 (0.50) KDM4EALDH1A1LMNAMAPTMEN1
SCHEMBL29062685 0.79 HRH4 (0.55) HRH4KDM4EALDH1A1HTT
SCHEMBL29063260 0.78 HRH4 (0.40) FLT3HRH4KDM4EALDH1A1LMNA
SCHEMBL21884856 0.74 AXL (0.49) FLT3ALDH1A1LMNAHPGDMAPT
SCHEMBL25779310 0.73 HRH4 (0.47) HRH4DRD2DRD3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof Pardes Biosciences, Inc. (US) 2022-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof CTRL, CTSV, CTSL FLT3 2640/4885PDGFRB 3175/4885PDGFRA 3762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.